Mednax Prices Private Offering of $400 Million Senior Notes Due 2030

Author's Avatar
Feb 03, 2022

Mednax, Inc. (NYSE: MD) (“Mednax”) announced today the pricing of $400.0 million aggregate principal amount of 5.375% Senior Notes due 2030 (the “Notes”) in a private offering (the “Offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The Offering is expected to close on February 11, 2022, subject to customary closing conditions.